Evidence of 14c-furazolidone metabolite binding to the hepatic DNA of trout

Drug Metabolism and Drug Interactions

Volumn 14, Issue 4, 1998, Pages 209-219

  Meng, J ^a   Mangat, S S ^a   Grudzinski, I P ^a   Law, F C P ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

Author keywords

DNA; Furazolidone; Rainbow trout

Indexed keywords

DNA; FURAZOLIDONE; NITROFURAN; ANTIINFECTIVE AGENT; CARBON; FOOD ADDITIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUACULTURE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; LIVER METABOLISM; METABOLITE; NONHUMAN; RAINBOW TROUT; ANIMAL; ANIMAL FOOD; LIVER; METABOLISM;

ANIMAL FEED; ANIMALS; ANTI-INFECTIVE AGENTS; AQUACULTURE; CARBON RADIOISOTOPES; DNA; FOOD ADDITIVES; FURAZOLIDONE; LIVER; ONCORHYNCHUS MYKISS;

EID: 0031593271     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.1998.14.4.209     Document Type: Article

References (17)

1. Herman RL, Bullock GL. Antimicrobials and fish: A review of drugs used to treat bacterial diseases of channel catfish and rainbow trout. Vet Hum Toxicol 1986; 28: 11-17.
2. McCalla DR. Mutagenicity of nitrofuran derivatives: review. Environ Mut 1983; 5: 745-765.
3. Ali BH. Pharmacology and toxicology of furazolidone in animals some recent research. Gen Pharmac 1989; 20: 557-563.
4. Vroomen LHM, Berghmans MCJ, Bladeren PJ, Groten JP, Vissink CJ, Kuiper HA. In vivo and in vitro metabolic studies of furazolidone: A risk evaluation. Drug Metab Rev 1990; 22: 663-676.
5. Cohen MN. Toxicity and carcinogenicity of nitrofurans. In: Bryan GB, ed. Carcinogens - A Comprehensive Survey, Vol. 4, Nitrofurans: Chemistry, Metabolism, and Carcinogenesis. New York: Raven Press, 1983; 171-231.
6. Basa J. Inter-strand cross-linking of Vibrio cholerae DNA induced by furazolidone: a quantitative assay by four simple methods. Mut Res 1995; 327: 5-15.
7. McCalla DR, Voutsinos D. On the mutagenesis of nitrofurans. Mut Res 1974; 26: 3-16.
8. Chatterjee SN, Benerjee SK, Pal AK, Basak J. DNA damage, prophage induction and mutation by furazolidone. Chem Biol Interact 1983; 45: 315-326.
9. Swaminathan S, Lower GM. Biotransformation and extraction of nitrofurans. In: Bryan GB, ed. Carcinogens - A Comprehensive Survey, Vol. 4, Nitrofurans: Chemistry, Metabolism, and Carcinogenesis. New York: Raven Press, 1978; 59-97.
10. 14C-furazolidone metabolites to the muscular and hepatic proteins of trout. Food Additiv Contam 1996; 13: 199-209.
11. FDA (Food and Drug Administration). Nitrofurans; Withdrawal of approval of new animal drug applications; final rule; final decision following a formal evidentiary public hearing. Federal Register 56, No. 164, 41902-42912, 1991.
12. Hoogenboom LAP, Kammen M, Berghmans MCJ, Koeman JH, Kuiper HA. The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone: a new analytical method for their detection. Fd Chem Toxicol 1991; 29: 321-328.
13. Ross JA, Nelson GB, Holden KL. DNA isolation from small tissue samples using salt and spermine. Nucleic Acids Res 1992; 19: 6053-6059.
14. Varanesi U, Stein JE, Hom T. Covalent binding of benzo[α]pyrene to DNA in fish liver. Biochem Biophys Res Comm 1981; 103: 780-787.
15. Zhang Q, Suorsa-Super K, Curtis LL. Temperature modulated Aflatoxin B1 hepatic disposition and formation and persistence of DNA adducts in rainbow trout. Toxicol Appl Pharmacol 1992; 113: 253-259.
16. Tatsumi K, Nakabeppu H, Takahashi Y, Kitamura S. Metabolism in vivo of furazolidone: evidence for formation of an open-chain carboxylic acid and α-ketoglutaric acid from the nitrofuran in rats. Arch Biochem Biophys 1984; 234: 112-116.
17. Klemencic J, Wong CY. Mutagenicity of nitrofurans. In: Bryan GB, ed. Carcinogens - A Comprehensive Survey, Vol. 4, Nitrofurans: Chemistry, Metabolism, and Carcinogenesis. New York: Raven Press, 1978; 99-131.